Quick Answer
Translational Development Acquisition Corp. reported Total Assets of $181.70 million for fiscal year 2025.
Translational Development Acquisition Corp. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $181.70M | +3.8% |
| 2024 | $175.00M | +8659008.3% |
| 2023 | $2.0K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $179.98M | — | +1.0% |
| June 30, 2025 | $178.18M | — | +0.9% |
| March 31, 2025 | $176.60M | — | +0.9% |
| December 31, 2024 | $175.00M | — | — |
- Translational Development Acquisition Corp. showed an increase of +3.8% in Total Assets compared to the prior fiscal year.
- Over the 2023–2025 period, Translational Development Acquisition Corp.’s total assets has grown by 8990339.2% (from $2.0 thousand to $181.70 million).
- The most recent figure is from Translational Development Acquisition Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: